NL176255C - METHOD FOR PREPARING PEPTIDES - Google Patents

METHOD FOR PREPARING PEPTIDES

Info

Publication number
NL176255C
NL176255C NLAANVRAGE7208757,A NL7208757A NL176255C NL 176255 C NL176255 C NL 176255C NL 7208757 A NL7208757 A NL 7208757A NL 176255 C NL176255 C NL 176255C
Authority
NL
Netherlands
Prior art keywords
preparing peptides
peptides
preparing
Prior art date
Application number
NLAANVRAGE7208757,A
Other languages
Dutch (nl)
Other versions
NL7208757A (en
NL176255B (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712132767 external-priority patent/DE2132767A1/en
Priority claimed from DE2202613A external-priority patent/DE2202613C3/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7208757A publication Critical patent/NL7208757A/xx
Publication of NL176255B publication Critical patent/NL176255B/en
Application granted granted Critical
Publication of NL176255C publication Critical patent/NL176255C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94Oxygen atom, e.g. piperidine N-oxide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C07K1/124Hydrazinolysis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NLAANVRAGE7208757,A 1971-07-01 1972-06-26 METHOD FOR PREPARING PEPTIDES NL176255C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712132767 DE2132767A1 (en) 1971-07-01 1971-07-01 Peptide prodn - in the presence of 1-hydroxybenzotriazole
DE2202613A DE2202613C3 (en) 1972-01-20 1972-01-20 Process for the production of peptides

Publications (3)

Publication Number Publication Date
NL7208757A NL7208757A (en) 1973-01-03
NL176255B NL176255B (en) 1984-10-16
NL176255C true NL176255C (en) 1985-03-18

Family

ID=25761356

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7208757,A NL176255C (en) 1971-07-01 1972-06-26 METHOD FOR PREPARING PEPTIDES

Country Status (12)

Country Link
JP (1) JPS5110201B1 (en)
AT (1) AT340067B (en)
BE (1) BE785790A (en)
CA (1) CA988079A (en)
DD (1) DD99570A5 (en)
DK (1) DK145715C (en)
FR (1) FR2144416A5 (en)
GB (1) GB1396801A (en)
HU (1) HU169326B (en)
IL (1) IL39788A (en)
NL (1) NL176255C (en)
SU (1) SU511852A3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1
KR102571783B1 (en) * 2022-12-16 2023-08-29 스트라토 주식회사 Search processing system performing high-volume search processing and control method thereof

Also Published As

Publication number Publication date
JPS5110201B1 (en) 1976-04-02
CA988079A (en) 1976-04-27
SU511852A3 (en) 1976-04-25
NL7208757A (en) 1973-01-03
NL176255B (en) 1984-10-16
AT340067B (en) 1977-11-25
BE785790A (en) 1973-01-03
DD99570A5 (en) 1973-08-12
FR2144416A5 (en) 1973-02-09
GB1396801A (en) 1975-06-04
ATA565672A (en) 1977-03-15
DK145715C (en) 1983-08-08
HU169326B (en) 1976-11-27
DK145715B (en) 1983-02-07
IL39788A (en) 1976-07-30
IL39788A0 (en) 1972-08-30

Similar Documents

Publication Publication Date Title
NL7415602A (en) METHOD FOR PREPARING PEPTIDES.
NL7408940A (en) METHOD FOR PREPARING PEPTIDES.
NL161179C (en) PROCESS FOR PREPARING POLYETHYLENE TERPHALATE
NL7505590A (en) PROCEDURE FOR PREPARING PEPTIDES WITH LH-RH / FSH-RH ACTION.
NL162932C (en) PROCESS FOR PREPARING ENTCOPOLYMERS.
NL7607987A (en) METHOD FOR PREPARING PEPTIDES.
NL7708070A (en) PROCEDURE FOR PREPARING TRANS-1-JEWEL--1-ALKINES.
NL166925C (en) METHOD FOR PREPARING PEPTIDES
NL170409C (en) IMPROVED METHOD FOR PREPARING DIMETHYL TEREPHALATE
NL176673C (en) PROCESS FOR PREPARING HYDRAZODICARBONAMIDE.
NL177208C (en) METHOD FOR PREPARING UNVALIENT ETHYNOLS
NL153548B (en) PROCESS FOR PREPARING METHYLCOBALAMINE.
NL162628C (en) PROCESS FOR PREPARING ALFA-OXOCARBONIC ACIDS.
NL176255C (en) METHOD FOR PREPARING PEPTIDES
NL166924C (en) METHOD FOR PREPARING PEPTIDES
NL175295C (en) PROCESS FOR PREPARING CYANACETYL CARBAMATES
NL177685C (en) METHOD FOR PREPARING AZINS
NL156126B (en) PROCESS FOR PREPARING 5-HYDROXY-1-TETRALONE.
NL152886B (en) METHOD FOR PREPARING POLYESTERS.
NL170000C (en) PROCESS FOR PREPARING 2-MERCAPTOBENZOTHIAZOL.
NL175815C (en) METHOD FOR PREPARING AZINS
NL171450C (en) METHOD FOR PREPARING ESTERS.
NL7416294A (en) METHOD FOR PURIFYING PEPTIDES.
NL161142B (en) PROCEDURE FOR PREPARING LACTAM COMPLEXES.
NL160798C (en) METHOD FOR PREPARING AN OCTYLPHENOL.

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent